ReviewPharmaceutics2021

Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists.

Sehwan Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.